-transparent.png){kind=logo}
OBJECTIVE Several untoward health effects of phthalates, which are a group of industrial chemicals with many commercial uses including personal-care products and plastic materials, have been defined. The most commonly used, di-(2-ethylhexyl)-phthalate (DEHP), is known to have antiandrogenic or estrogenic effects or both. Mono-(2-ethylhexyl)-phthalate (MEHP) is the main metabolite of DEHP. In this study, we aimed to determine the plasma DEHP and MEHP levels in pubertal gynecomastia cases. METHODS The study group comprised 40 newly diagnosed pubertal gynecomastia cases who were admitted to Hacettepe University Ihsan Doğramaci Children's Hospital. The control group comprised 21 age-matched children without gynecomastia or other endocrinologic disorder. Plasma DEHP and MEHP levels were measured by using high-performance liquid chromatography. Serum hormone levels were determined in some pubertal gynecomastia cases according to the physician's evaluation. RESULTS Plasma DEHP and MEHP levels were found to be statistically significantly higher in the pubertal gynecomastia group compared with the control group (P < .001) (DEHP, 4.66 +/- 1.58 and 3.09 +/- 0.90 microg/mL, respectively [odds ratio: 2.77 (95% confidence interval: 1.48-5.21)]; MEHP, 3.19 +/- 1.41 and 1.37 +/- 0.36 microg/mL [odds ratio: 24.76 (95% confidence interval: 3.5-172.6)]). There was a statistically significant correlation between plasma DEHP and MEHP levels (r: 0.58; P < .001). In the pubertal gynecomastia group, no correlation could be determined between plasma DEHP and MEHP levels and any of the hormone levels. CONCLUSIONS DEHP, which has antiandrogenic or estrogenic effects, may be an etiologic factor in pubertal gynecomastia. These results may pioneer larger-scale studies on the etiologic role of DEHP in pubertal gynecomastia.
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
July 1983,
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
August 1973,
Zeitschrift fur Kinderheilkunde,
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
October 2005,
Journal of pediatric endocrinology & metabolism : JPEM,
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
May 2002,
Journal of pediatric endocrinology & metabolism : JPEM,
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
January 1972,
Deutsche medizinische Wochenschrift (1946),
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
August 2002,
Minerva pediatrica,
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
January 1994,
Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica,
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
November 1977,
The Journal of pediatrics,
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
January 1978,
The Journal of pediatrics,
Erdem Durmaz, and
Elif N Ozmert, and
Pinar Erkekoglu, and
Belma Giray, and
Orhan Derman, and
Filiz Hincal, and
Kadriye Yurdakök
October 2016,
Breast care (Basel, Switzerland),
